US Broker Ratings

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 23.72% Potential Upside for Investors

Align Technology, Inc. (NASDAQ: ALGN), a leader in the healthcare sector specializing in medical instruments and supplies, is currently drawing considerable attention from investors. With its cutting-edge Invisalign clear aligners..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring Growth and Dividend Potential in Biotech

Royalty Pharma plc (NASDAQ: RPRX) operates at the intersection of innovation and investment within the healthcare sector, focusing on biopharmaceutical royalties. As an intriguing player in the biotechnology industry, Royalty..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings and Promising Growth Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), an innovative player in the biotechnology sector, continues to capture investor attention with its robust portfolio of pharmaceutical products and promising pipeline developments. Headquartered in..

Lantheus Holdings, Inc. (LNTH) Investor Outlook: Exploring a 13.16% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) is making waves in the healthcare sector, particularly in the niche market of specialty and generic drug manufacturing. This Massachusetts-based company, with a market cap..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Growth Amidst Market Challenges

Illumina, Inc. (NASDAQ: ILMN), a pivotal player in the healthcare sector specializing in diagnostics and research, stands at a fascinating crossroads. With a market capitalization of $31.03 billion, the San..

Veeva Systems Inc. (VEEV) Stock Analysis: Navigating a Potential 19.81% Upside with Innovative Cloud Solutions

Veeva Systems Inc. (NYSE: VEEV), a prominent player in the healthcare sector, is capturing investor attention with its robust growth potential. Headquartered in Pleasanton, California, Veeva is a trailblazer in..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unveiling a 31.42% Potential Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO) presents a compelling opportunity for investors focused on the biotechnology sector. With a market capitalization of $15.69 billion, this U.S.-based healthcare company is making significant..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 24% Upside in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector, specifically within the medical care facilities industry, offers intriguing potential for investors seeking exposure to the home..

West Pharmaceutical Services (WST) Stock Analysis: A Potential 18.7% Upside Awaits Investors

For investors navigating the healthcare sector, West Pharmaceutical Services, Inc. (NYSE: WST) presents a compelling opportunity. As a key player in the medical instruments and supplies industry, West Pharmaceutical Services..

Summit Therapeutics Inc. (SMMT) Investor Outlook: Exploring a Potential 117.69% Upside

Investors with a keen eye on the biotechnology sector may find Summit Therapeutics Inc. (NASDAQ: SMMT) to be a compelling opportunity, given the company’s strategic focus and the considerable potential..

ResMed Inc. (RMD) Stock Analysis: A Look at a 17.83% Potential Upside for Healthcare Investors

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, is making waves in the medical instruments and supplies industry. With a solid market capitalization of $30.6 billion, the..

Tempus AI, Inc. (TEM) Stock Analysis: A Healthcare Tech Powerhouse with 48% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM), a pivotal player in the healthcare technology sector, has garnered significant attention in the investment community due to its innovative approach and strategic collaborations with..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unpacking the 111.52% Potential Upside

Telix Pharmaceuticals Limited (TLX) is capturing the attention of investors, not just in Australia but globally, due to its ambitious pipeline in the biotechnology sector. With a market capitalization of..

Doximity, Inc. (DOCS) Stock Analysis: Evaluating a 17.70% Potential Upside in Healthcare Innovation

Doximity, Inc. (DOCS) presents an intriguing prospect for investors looking to tap into the burgeoning field of digital health services. As a dominant player in the Health Information Services industry,..

The Ensign Group, Inc. (ENSG): Investor Outlook with a 23.48% Potential Upside

Investors eyeing The Ensign Group, Inc. (NASDAQ: ENSG) might find its current market position appealing, as a confluence of factors suggests potential upside. With a robust market capitalization of $10.38..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: 87.96% Potential Upside Beckons Investors

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is a pioneering biotechnology company at the forefront of ribonucleic acid interference (RNAi) therapeutics development. With a robust pipeline and an impressive array of marketed..

Axsome Therapeutics, Inc. (AXSM): Investor Outlook on a Biotech Stock with a 29% Potential Upside

Axsome Therapeutics, Inc. (NASDAQ: AXSM) stands out as an intriguing player in the biotechnology sector, primarily focused on developing therapies for central nervous system (CNS) disorders. With a significant market..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Promising Biotech with a 10.38% Upside Potential

In the fast-evolving world of biotechnology, Revolution Medicines, Inc. (NASDAQ: RVMD) stands out as a formidable player with a focus on precision oncology. This Redwood City, California-based company is making..

ICON plc (ICLR) Stock Analysis: Evaluating Performance & 13.45% Potential Upside

ICON plc (NASDAQ: ICLR), a leading clinical research organization headquartered in Dublin, Ireland, is making waves in the healthcare sector with its expansive range of outsourced development and commercialization services...

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 7.62% Upside Potential in the Medical Devices Sector

Smith & Nephew SNATS, Inc. (SNN), a prominent player in the healthcare sector, commands significant attention from investors due to its robust presence in the medical devices industry. Based in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds